Stay updated on Lebrikizumab Long-term Safety Efficacy AD Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Recruitment status is updated to 'No longer looking for participants', signaling that the study is closed to new participants, and several help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study). Publications references were updated by adding a 2026 Lebrikizumab study citation and removing the older 2025 citation, and the Intervention/Treatment heading formatting was adjusted.
    Difference
    0.1%
    Check dated 2026-06-12T00:27:20.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page’s Revision tag changed from v3.5.4 to v3.5.5, indicating a new build of the page. This appears to reflect a behind-the-scenes update rather than a substantive change to the study information.
    Difference
    0.0%
    Check dated 2026-06-05T00:31:54.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, indicating a new version of the page/documentation has been published. This appears to be a minor, behind-the-scenes update rather than a substantive change to the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-05-21T18:38:14.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Taiwan site listing now specifies Taoyuan City rather than Taoyuan, clarifying the exact location.
    Difference
    0.0%
    Check dated 2026-05-07T09:42:40.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision: v3.5.3 now appears, replacing Revision: v3.5.2. This indicates a version update to the page’s documentation or release notes rather than changes to study data or core content.
    Difference
    0.0%
    Check dated 2026-04-30T03:21:21.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The page’s software/site revision indicator was updated from v3.5.0 to v3.5.2, with no visible changes to the study information.
    Difference
    0.0%
    Check dated 2026-04-22T18:16:53.000Z thumbnail image

Stay in the know with updates to Lebrikizumab Long-term Safety Efficacy AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.